• Aquestive Therapeutics President and CEO Daniel Barber sold 8,257 shares of common stock on May 15, 2026.
• The shares sold at a weighted average price of $4.29.
• Barber held 660,574 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aquestive Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-006532), on May 18, 2026, and is solely responsible for the information contained therein.